Macquarie Group
NITE

Macquarie Group’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Macquarie Group’s Portfolio NITE Stock Details NITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-600
Closed -$8K – 2514
2017
Q4 		$8K Buy
+600
New +$10.8K ﹤0.01% 2325

Other funds holding NITE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return

Macquarie Group's NITE Position: Q1 2018 in Review

Macquarie Group sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q1 2018, closing a stake of 600 shares — an estimated $8K sold.

Macquarie Group first reported a position in NITE in Q4 2017 and held it in 1 quarter. The position peaked at $8K in Q4 2017. 20 funds tracked by Wall St. Rank hold NITE as of Q1 2018.

  • Macquarie Group reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q1 2018 after selling out during the quarter.
  • Macquarie Group sold 600 Nightstar Therapeutics plc American Depositary Shares shares in Q1 2018, an estimated $8K.
  • Macquarie Group first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q4 2017 and held it in 1 quarter.
  • Macquarie Group's Nightstar Therapeutics plc American Depositary Shares position peaked at $8K in Q4 2017.
  • 20 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q1 2018.

Based on Macquarie Group's 13F filing for Q1 2018, filed 11 May 2018.